GENINUS Inc. (KOSDAQ:389030)
South Korea · Delayed Price · Currency is KRW 1,805.00
-12.00 (-0.66%)
At close: Sep 11, 2026
GENINUS Market Cap
GENINUS has a market cap or net worth of 71.1 billion as of September 11, 2026. Its market cap has increased by 10.01% in one year.
Market Cap
71.10B
Enterprise Value
50.76B
Revenue
11.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,805.00
ChartMarket Cap Chart
Since November 8, 2021, GENINUS's market cap has decreased from 145.65B to 71.10B, a decrease of -51.18%. That is a compound annual growth rate of -13.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 71.10B | -39.09% |
| Dec 30, 2025 | 116.73B | 154.55% |
| Dec 30, 2024 | 45.86B | -47.60% |
| Dec 28, 2023 | 87.52B | 25.13% |
| Dec 29, 2022 | 69.94B | -49.53% |
| Dec 30, 2021 | 138.58B | -4.85% |
| Nov 8, 2021 | 145.65B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 234.26B |
| 3billion | 136.84B |
| GC Medical Science | 74.41B |
| Cytogen | 70.65B |
| Inventera | 68.98B |
| Protia | 67.62B |
| HLB Panagene | 53.45B |
| Seoulin Bioscience | 36.62B |